SEC 13F manager · CIK 0001536411

Duquesne Family Office 13F holdings

Duquesne Family Office's latest SEC 13F top holdings and quarterly rebalancing. 13F data is a report-period snapshot, not a live portfolio.

Duquesne's 13F often combines macro positioning with selective growth and cyclical equity exposure.

Open dashboard

Watch

What to watch in this manager's 13F

The useful signal is not the holding change alone, but the company question it creates.

-Which companies express rate, AI, commodity, or cyclical exposure.
-Whether fast quarterly position changes line up with filing evidence.
-Whether top concentrated holdings reflect macro theses or company-specific theses.

Questions

Representative questions

Use these as starting points to move from a 13F signal into company filing research.

01Separate Duquesne top holdings into macro theses and company-specific theses.
02Check whether increased Duquesne positions fit the current macro backdrop based on filings.
03Review whether reduced Duquesne names show rising filing risks.
04Compare AI, energy, and rate-sensitive names through cash-flow evidence.

Filing summary

Report period

Mar 31, 2026

13F-HR

Filing date

May 15, 2026

0001536411-26-000004

Top holdings value

$2.9M

30 positions

Top 10 weight

55.6%

Dec 31, 2025

Top holdings

Public 13F information table summary sorted by reported market value.

IssuerMarket valueWeightChange

Natera Inc

632307104

$612,69118.14%Increased

Insmed Inc

457669307

$188,7175.59%Decreased

Taiwan Semiconductor Manufac

874039100

$167,3804.96%Decreased

Ishares Inc

464286400

$162,3134.81%Increased

Invesco Exchange Traded Fd T

46137V357

$157,5664.67%New

Ypf Sociedad Anonima

984245100

$149,5664.43%Increased

Ishares Inc

464286400

$131,9153.91%Decreased

Bbb Foods Inc

G0896C103

$109,9723.26%Increased

Alcoa Corp

013872106

$99,0572.93%Increased

Newamsterdam Pharma Company

N62509109

$98,2752.91%Decreased

Sea Ltd

81141R100

$91,0832.7%Increased

Stmicroelectronics N V

861012102

$90,2752.67%Increased

Quarterly rebalancing signals

Weight increases

Natera Inc

632307104

+5.34%

Invesco Exchange Traded Fd T

46137V357

+4.67%

Ypf Sociedad Anonima

984245100

+3.94%

Stmicroelectronics N V

861012102

+2.23%

Ishares Inc

464286400

+1.82%

Weight decreases

Select Sector Spdr Tr

81369Y605

-6.7%

Invesco Exchange Traded Fd T

46137V357

-5%

아마존

AMZN

-3.51%

알파벳

GOOGL

-2.68%

Coupang Inc

22266T109

-2.06%

How to interpret 13F data

Duquesne positions can change quickly, so the public 13F may be stale by the time it is read.
Macro hedges, private positions, and derivatives are not visible in a standard 13F view.
13F data is published after quarter end, so holdings may have changed.
Short positions, some non-U.S. holdings, and confidential treatment items may not be visible.
KRW Ontology treats 13F as input for follow-up filing research, not as a buy signal.

FAQ

What is this 13F page for?

Use it to see which U.S. listed equities a manager disclosed, then turn those holdings into follow-up company and risk research questions.

Continue with another flow

SEC 13F manager · CIK 0001536411

Duquesne Family Office 13F holdings

Duquesne Family Office's latest SEC 13F top holdings and quarterly rebalancing. 13F data is a report-period snapshot, not a live portfolio.

Duquesne's 13F often combines macro positioning with selective growth and cyclical equity exposure.

Open dashboard

Watch

What to watch in this manager's 13F

The useful signal is not the holding change alone, but the company question it creates.

-Which companies express rate, AI, commodity, or cyclical exposure.
-Whether fast quarterly position changes line up with filing evidence.
-Whether top concentrated holdings reflect macro theses or company-specific theses.

Questions

Representative questions

Use these as starting points to move from a 13F signal into company filing research.

01Separate Duquesne top holdings into macro theses and company-specific theses.
02Check whether increased Duquesne positions fit the current macro backdrop based on filings.
03Review whether reduced Duquesne names show rising filing risks.
04Compare AI, energy, and rate-sensitive names through cash-flow evidence.

Filing summary

Report period

Mar 31, 2026

13F-HR

Filing date

May 15, 2026

0001536411-26-000004

Top holdings value

$2.9M

30 positions

Top 10 weight

55.6%

Dec 31, 2025

Top holdings

Public 13F information table summary sorted by reported market value.

IssuerMarket valueWeightChange

Natera Inc

632307104

$612,69118.14%Increased

Insmed Inc

457669307

$188,7175.59%Decreased

Taiwan Semiconductor Manufac

874039100

$167,3804.96%Decreased

Ishares Inc

464286400

$162,3134.81%Increased

Invesco Exchange Traded Fd T

46137V357

$157,5664.67%New

Ypf Sociedad Anonima

984245100

$149,5664.43%Increased

Ishares Inc

464286400

$131,9153.91%Decreased

Bbb Foods Inc

G0896C103

$109,9723.26%Increased

Alcoa Corp

013872106

$99,0572.93%Increased

Newamsterdam Pharma Company

N62509109

$98,2752.91%Decreased

Sea Ltd

81141R100

$91,0832.7%Increased

Stmicroelectronics N V

861012102

$90,2752.67%Increased

Quarterly rebalancing signals

Weight increases

Natera Inc

632307104

+5.34%

Invesco Exchange Traded Fd T

46137V357

+4.67%

Ypf Sociedad Anonima

984245100

+3.94%

Stmicroelectronics N V

861012102

+2.23%

Ishares Inc

464286400

+1.82%

Weight decreases

Select Sector Spdr Tr

81369Y605

-6.7%

Invesco Exchange Traded Fd T

46137V357

-5%

아마존

AMZN

-3.51%

알파벳

GOOGL

-2.68%

Coupang Inc

22266T109

-2.06%

How to interpret 13F data

Duquesne positions can change quickly, so the public 13F may be stale by the time it is read.
Macro hedges, private positions, and derivatives are not visible in a standard 13F view.
13F data is published after quarter end, so holdings may have changed.
Short positions, some non-U.S. holdings, and confidential treatment items may not be visible.
KRW Ontology treats 13F as input for follow-up filing research, not as a buy signal.

FAQ

What is this 13F page for?

Use it to see which U.S. listed equities a manager disclosed, then turn those holdings into follow-up company and risk research questions.